|
OR (n)
|
NR (n)
|
P
|
Test
|
---|
Age
| | | | |
Median (range)
|
51,5 (35 – 67)
|
47,5 (29 – 68)
|
0.3
|
Student t
|
≤ 45 anos
|
12
|
7
| | |
>45 anos
|
35
|
7
|
0.1
|
Fisher
|
Menopausal Status
| | | | |
Post
|
24
|
8
| | |
Pre
|
22
|
6
|
0.9
|
x2
|
CT cycle (range)
|
3 (2 – 5)
|
3 (2 – 4)
|
0.4
|
Mann-Whitney
|
CS
| | | | |
IIA
|
8
|
4
| | |
IIB
|
15
|
4
| | |
IIIA
|
5
|
2
| | |
IIIB
|
14
|
4
| | |
IIIC
|
3
|
0
|
0.78
|
x2
|
Grade
| | | | |
I
|
10
|
6
| | |
II
|
27
|
5
| | |
III
|
8
|
3
|
0.2
|
x2
|
ER
| | | | |
Positive
|
32
|
12
| | |
Negative
|
12
|
2
|
0.48
|
Fisher
|
PR
| | | | |
Positive
|
20
|
7
| | |
Negative
|
25
|
7
|
0.76
|
Fisher
|
ER/PR
| | | | |
Positive
|
16
|
7
| | |
Negative
|
22
|
7
|
0.75
|
Fisher
|
P53
| | | | |
Positive
|
16
|
2
| | |
Negative
|
30
|
12
|
0.19
|
Fisher
|
P21
| | | | |
Positive
|
15
|
5
| | |
Negative
|
31
|
9
|
1
|
Fisher
|
HER-2
| | | | |
Positive
|
10
|
1
| | |
Negative
|
36
|
13
|
0.43
|
Fisher
|
- OR = objective response; NR = no response; n = number of patients; CT = chemotherapy; CS = clinical staging; Grade = histological grade (Bloom-Richardson); ER = estrogen receptor; PR = progesterone receptor.